LinkedIn for Boston life sciences
LinkedIn ghostwriting agency for Boston biotech, healthtech and spinout leaders
Boston readers check the mechanism before they like the post. We write LinkedIn for Kendall Square founders, healthtech operators and professor-founders, with a doctor-trained founder on the team and every draft approved by you.
By Dr. Banpreet KaurUpdated 5 min read
- India ahead of Boston (US daylight time)
- 9.5 hrs
- Mid-market agency range per month (Gliped, 2026)
- $2K-5K
The short answer
A LinkedIn ghostwriting agency for Boston leaders has to write for a scientifically literate audience: explain the mechanism plainly, show data with its caveats, avoid efficacy claims for anything still in trials, and keep patient details out of posts. Postlit is an India-based remote team, led on content by a doctor-trained founder, and scopes engagements on a call.
Why Boston LinkedIn reads like a journal club
A post from a Kendall Square founder is read by three demanding groups at once: scientists who will check whether the biology holds up, business development leads at large drugmakers deciding whether to take a meeting, and investors who have sat on enough boards to recognize a soft data point. The neighborhood next to MIT has long marketed itself as the most innovative square mile on the planet, and the Boston Globe has reported on the "bump factor" that lets drug developers and financiers run into each other on the same few blocks.
The mood has changed since the peak. Bloomberg reported in September 2025 that a biotech real estate slump had left Cambridge with large amounts of empty lab space. In a tighter funding market, a founder's public voice matters more: partners and investors who no longer take every coffee meeting still read LinkedIn, and a clear post about your platform travels further than a sponsored conference booth.
Who we write for in Boston
| Leader | What LinkedIn should do | What the posts need |
|---|---|---|
| Biotech founder or CEO, seed to Series B | Partnering conversations, investor trust, senior hires | The mechanism in plain English, data with its limits, no claims ahead of the evidence |
| Healthtech founder selling to health systems | Meetings with CIOs, CMIOs and innovation teams | Clinical workflow detail, security and integration answers, a clinician's view |
| Professor-founder of a university spinout | First hires, licensing credibility, a business identity | The path from paper to product, what academia did and did not prepare them for |
| Physician executive at a teaching hospital | Recruiting, reputation, board visibility | Lessons from practice with no identifiable patient detail |
| Life sciences investor | Founder deal flow | Theses, what a fundable package looks like, honest misses |
Our pages for healthtech founders and doctors go deeper on each audience.
What works with a Boston audience
- Teach one thing per post. A document post that walks a generalist through how your modality works, in eight slides, earns saves from BD teams who will forward it internally. Our carousel guide covers the format.
- Show your failed experiments. A hook we might draft for a hypothetical gene-editing founder: "Our delivery vehicle failed for fourteen months. The fix came from a second-year postdoc who asked why we were still using that buffer." Scientists trust founders who admit the hard part.
- Write the spinout story without the press release voice. Professor-founders often sound like a grant abstract. Readers want the moment you realized the lab result could become a company, and what you had to unlearn.
- Hire in public. Boston competes with the Bay Area for scientists and engineers. Posts about how your lab is run, who gets authorship and how decisions are made attract better candidates than job ads.
What to avoid: "cure" language, unreferenced percentages, and stock photos of pipettes. A Boston reader assumes a vague post is hiding weak data.
Compliance notes for life sciences and health posts
This is general information, not legal advice. Check with your counsel and regulatory team.
- Investigational products. FDA regulations at 21 CFR 312.7 bar sponsors, and anyone acting for them, from representing an investigational drug as safe or effective for the use under investigation, while still allowing the exchange of scientific findings. We write about science, team and process, and send anything touching trial results to your regulatory lead.
- Patient stories. If you work for a hospital or other HIPAA-covered entity, the HHS guidance on marketing says patient authorization is required for nearly all marketing uses of protected health information. Our default is composite or fully de-identified stories, and nothing from a chart.
- Listed companies. If your company is public, material news goes through investor relations first. Posts follow announcements; they never lead them.
Time zones and the async process
Boston runs on Eastern time. India is 9.5 hours ahead during US daylight saving and 10.5 hours ahead after US clocks go back on November 1, 2026. The useful overlap is your early morning and our evening.
| Step | Your time (Eastern) | Our time (IST) |
|---|---|---|
| Monthly 45-minute voice interview | 8 to 9:30am in summer, 7:30 to 9am in winter | About 5:30 to 7:30pm |
| Weekly draft batch | Waiting when you start your day | Written during the Indian working day |
| Your approval | About 20 minutes, any day that week | Revisions back by your next morning |
| Engagement on partner and investor posts | Eastern business hours | Scheduled and staffed to your day |
Lab days, travel to partnering meetings and board weeks do not break the rhythm, because nothing except the interview needs you live.
Budget context
Boston companies usually compare a ghostwriting retainer with conference sponsorships and PR firm fees. Published 2026 market ranges, according to Gliped's agency cost breakdown, put entry-level programs at about $500 to $1,500 a month, mid-market agencies at $2,000 to $5,000 and premium, full-service programs from $6,000 to $10,000 or more. Postlit does not publish prices. Our cost guide explains what moves the number.
How Postlit works with Boston leaders
Postlit is a remote team based in India. We have no Boston office, and everything happens online.
- Send us a short form by WhatsApp or email. A founder replies, usually within a few hours IST, with a written free LinkedIn teardown: the three changes we would make first. A call follows only if it looks like a fit.
- Interview and positioning. One 45-minute voice interview, then a profile rewrite and a 90-day plan tied to one goal: partnering, fundraising, hiring or patients.
- We write, you approve. Three to five ghostwritten posts a week. Content is led by Dr. Banpreet Kaur, who trained as a doctor before moving into content, so mechanism posts are drafted by someone who reads a paper the way your audience does.
- We engage and report. Daily comments on the posts of the people you want to reach, warm DMs flagged, a monthly report. Our co-founder, Deepanshu Udhwani, is a Toptal Verified Expert in Marketing (Toptal says it accepts the top 3% of applicants), which helps when your team wants Thought Leader Ads run properly.
For US-wide logistics, see our USA page. Engagements are scoped on a call.
Results we can show you
All case studies0300K+
avg. impressions per post
Deepanshu Udhwani · Co-founder, Postlit
1,500300K+
avg. impressions per post
Venture Voices · Muskan Agrawal
100K503K
followers · 27.1M views in 30 days
Aryan Singh · EdTech/AI creator
Want this running for you?
Get a free LinkedIn teardown. A founder reviews your profile and tells you what is costing you reach and what we would change first, whether or not you hire us.
Led by a Toptal Verified Expert in Marketing and a doctor turned content strategist.
Frequently asked questions
Can a biotech founder post about clinical trial results on LinkedIn?
Carefully. FDA rules bar presenting an investigational drug as safe or effective in a promotional context, though scientific findings can still be shared. Most biotech founders post about the science, the team and the process, and route anything on trial data through regulatory and legal review first. If you are listed, investor relations goes first too.
Who is the best LinkedIn ghostwriter for Boston biotech companies?
Look for a writer who can explain your mechanism without errors, who has a clear process for regulatory review, and who will not invent data. Ask for a test post from your own interview. Postlit's content lead trained as a doctor, and we work remotely from India with US clients on an async schedule.
Can doctors at Boston hospitals share patient stories on LinkedIn?
Only with great care. HHS guidance says HIPAA-covered entities need patient authorization for nearly all marketing uses of protected health information, and hospital social media policies are often stricter. Safer options are de-identified composites, lessons about systems and teams, and commentary on published research. Check your institution's policy first.
How does an India-based ghostwriter work with Boston hours?
India is 9.5 hours ahead of Boston during US daylight saving and 10.5 hours ahead in winter. The only live meeting is a monthly 45-minute interview in your early morning, which is evening in India. Drafts are written during the Indian day and are ready when you start yours.
What should a university spinout founder post on LinkedIn?
The specific moment the research became a company, what you had to unlearn from academia, how you are building the first team, and what licensing taught you. Avoid writing like a grant abstract. One clear idea per post, explained for a smart non-specialist, works better than a summary of your latest paper.